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Abstract
Background The aim of this study was to assess the usefulness of protective negative-pressure wound therapy (NPWT) in 
the reduction of wound healing complications (WHC) and surgical site infections (SSI) after diverting ileostomy closure in 
patients who underwent surgery for colorectal cancer.
Methods In this prospective randomized clinical trial in a tertiary academic surgical center, patients who had colorectal 
cancer surgery with protective loop ileostomy and were scheduled to undergo ileostomy closure with primary wound closure 
from January 2016 to December 2018 were randomized to be treated with or without NPWT. The primary endpoint was the 
incidence of WHC. Secondary endpoints were incidence of SSI, length of postoperative hospital stay (LOS), and length of 
complete wound healing (CWH) time.
Results We enrolled 35 patients NPWT (24 males [68.6%]; mean age 61.6 ± 11.3 years), with NPWT and 36 patients (20 
males [55.6%]; mean age 62.4 ± 11.3 years) with only primary wound closure (control group). WHC was observed in 11 
patients (30.6%) in the control group and 3 (8.57%) in the NPWT group (p = 0.020). Patients in the NPWT group had a 
significantly lower incidence of SSI (2 [5.71%] vs. 8 [22.2%] in the control group; p = 0.046) as well as significantly shorter 
median CWH (7 [7–7] days vs. 7 [7–15.5] days, p = 0.030). There was no difference in median LOS between groups (3 
[2.5–5] days in the control group vs. 4 [2–4] days in the NPWT group; p = 0.072).
Conclusions Prophylactic postoperative NPWT after diverting ileostomy closure in colorectal cancer patients reduces the 
incidence of WRC and SSI.
Clinical trial registration clinicaltrials.gov (NCT04088162).
Keywords Prophylactic negative pressure wound therapy · Ileostomy closure · Prevention of wound-related complications · 
Colorectal cancer operation · Randomized controlled trial
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Introduction
Surgeries for colorectal cancer, especially procedures involv-
ing the lower rectum, are associated with a very high percent-
age of complications [1–3]. Despite the current recomsmenda-
tion for primary anastomosis after a resection procedure, such 
treatment is associated with a significant risk of anastomotic 
leak (up to 20% = [4, 5]). One way to reduce the risk of leak 
is to use a diverting ileostomy [6, 7]. Although this is cur-
rently considered a standard treatment, especially in the group 
of patients undergoing neoadjuvant radiotherapy or chemo-
radiotherapy, the technique still has its drawbacks, such as 
the necessity to perform an additional surgical operation for 
ileostomy closure, which has a high risk of wound healing 
complications, particularly surgical site infections (SSI) [8, 9]. 
To reduce the frequency of these complications, novel guide-
lines published in 2017 recommend using the purse-string 
suture technique [9–11]. However, this has been associated 
with as much as a fivefold increase in healing time, as well 
as less desirable cosmetic effects, in patients without SSI [12, 
13]. Negative-pressure wound therapy (NPWT) is currently 
a widely used method of treatment in various types of infec-
tious complications, potentially providing the opportunity 
to prevent infectious complications after surgery [14, 15] by 
combining the benefits of both postoperative wound closure 
techniques: reduced healing time, compared to primary clo-
sure, and reduced risk of infectious complications, compared 
to purse-string techniques.
The aim of this randomized controlled trial was to assess 
the usefulness of postoperative NPWT in the reduction of 
postoperative wound-healing complications (WHC) and SSI 
after diverting ileostomy closure in patients who underwent 
colorectal resection for cancer.
Materials and methods
Patients
A randomized controlled trial was conducted between January 
2016 and December 2018 in a tertiary referral center, Uni-
versity Hospital (Krakow, Poland). The trial was registered at 
clinicaltrials.gov (NCT04088162) after approval of the pro-
tocol by ethics committee of Jagiellonian University Medical 
College (#1072.6219.263.2019). The trial was designed as a 
single-center, randomized controlled, superiority trial with two 
parallel intervention arms.
Participants
Patients aged ≥ 18 years with a history of surgery for colo-
rectal cancer, including formation of the protective ileos-
tomy, who were scheduled to undergo ileostomy closure 
as an elective procedure, were randomly divided into two 
groups: Group 1 to undergo postoperative NPWT and Group 
2, a control group to undergo customary care (without post-
operative NPWT). Patients were enrolled after providing 
informed consent on admission. Exclusion criteria were 
emergency/urgent operation, active infection, operations 
other than ileostomy closure, or parastomal hernioplasty. 
Patients who required a second operation or transfer to the 
intensive care unit or other hospital wards because of non-
infectious complications within the first week after surgery 
were also excluded from the analysis.
Randomization
The 1:1 randomization with concealment was achieved 
using a random number generator (even/odd) [16]. Until the 
end of the operation, patients did not know to which group 
they were assigned. The randomization process and assign-
ment of the patients to the groups were performed by a trial 
researcher who was not directly involved in the operation or 
postoperative care of the patient. Operating surgeons were 
also blinded to the randomization. The NPWT dressing was 
set up at the end of the operation in sterile conditions in 
the operating room by one and the same person (the desig-
nated surgeon, a member of the research team) not directly 
involved in the operation or postoperative patient care.
Sample size calculation
Our previous observations found the primary endpoint inci-
dence in our population to be 33%, which was consistent 
with the data available in the literature [8, 9]. Additionally, a 
previous pilot study demonstrated that NPWT had decreased 
the incidence of WHC by 70–85% [17]. To demonstrate that 
NPWT decreased WHC by 80%, a total sample size of 70 
subjects was needed for an alpha of 0.05 and 80% power. 
Thus, with expectations of omissions, we sought a total sam-
ple size of 38 patients in each arm.
Procedures
Patients’ demographics, possible SSI risk factors, including 
age, sex, body mass index (BMI), active smoking, preopera-
tive immunosuppressive treatment, incidence of comorbidi-
ties, amount of intraoperative bleeding, and surgery duration 
were prospectively collected.
Surgical technique
All patients enrolled in the study had previously undergone 
a resection procedure for colorectal cancer with the simul-
taneous formation of a diverting loop ileostomy 20–30 cm 
proximally from the ileocecal valve at the ileal loop, which 
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was delivered through a circular incision on the right lower 
abdominal wall without mesenteric torsion. Ileostomy clo-
sure, as a second operation, was performed approximately 
6 months after initial surgery, after adjuvant chemotherapy 
(if necessary). Patients with American Joint Committee on 
Cancer—AJCC—stage 0 or 1 had the ileostomy removal 
procedure performed much earlier, as early as 14 days, after 
the histopathological examination results were obtained. 
At ileostomy closure, a circumferential incision around the 
ileostomy was performed. Adhesions were gently detached 
from the abdominal wall with scissors. After small bowel 
mobilization, the short-segment small bowel resection 
(approximately 15–25 cm) was performed. Anastomosis was 
performed via end-to-end single polydioxanone (PDS) Plus 
4–0 running suture. Wound closure was done along three 
layers, including the peritoneum layer, rectus abdominis 
fascia, and subcutaneous layer. 2–0 absorbable PDS Plus 
running suture was used for peritoneum and fascia layer, and 
3–0 Vicryl Plus single sutures were used to close the subcu-
taneous layer. In the five cases of parastomal hernia (three in 
the NPWT group and two in the control group) it was neces-
sary to perform hernia repair using a polypropylene mesh, 
as in the sub-lay method. In those patients, the silicone drain 
was placed in the subfascial layer and removed at 2 or 3 
postoperative days (after exudation reduction to less than 
30 ml/day). In the control group, the skin was closed by six 
to eight single non-absorbable Monosyn 3–0 loose sutures 
every 7–9 mm, and a sterile wound dressing was placed. 
In the NPWT group, the skin was closed with 4–6 single 
non-absorbable Monosyn 3–0 loose sutures every 1 cm. A 
NANOVA negative-pressure dressing was placed over the 
entire length of the incision. Thanks to the use of NPWT, 
which stabilizes wound edges, we were able to place less 
skin sutures without the risk of wound dehiscence. NPWT 
also provides the opportunity to evacuate exudate from the 
subcutaneous tissue in sterile conditions and prevent the for-
mation of a seroma or hematoma. In the control group, the 
first dressing change was made 48 h after the operation, and 
thereafter dressings were changed daily until the removal 
of sutures on postoperative day 7. In the NPWT group, the 
NANOVA dressing was taken out at 72 h. Three Steri-Strips 
were placed between the sutures, and a standard sterile 
dressing was placed. The dressing was then changed every 
24 h until the removal of sutures on postoperative day 7.
Perioperative care
All patients received second-generation cephalosporin 
(20 mg/kg) 30 min before the incision. On postoperative 
day 1, patients were fully mobilized and received a standard 
oral liquid diet with a volume restriction of 1 l. Patients with 
good diet tolerance were fed with a standard hospital diet 
from postoperative day 2. Perioperative care of patients in 
this study was compliant with the enhanced recovery after 
surgery (ERAS) protocol in colorectal surgery [18].
Healing was evaluated during dressing changes in the 
ward and then during routine check-ups in the outpatient 
clinic on postoperative days 7 and 14. Patients who noticed 
any abnormalities related to wound healing contacted the 
outpatient clinic by telephone and were admitted for an 
additional visit. After 30 days, the patients were contacted 
by telephone to obtain information about possible abnor-
malities related to healing and were asked to send a photo 
of the healed wound by e-mail. ForWHC, the frequency of 
monitoring visits was based on clinical status. The last visit 
to the outpatient clinic was made approximately 2 weeks 
after CWH.
End point criteria
The primary endpoint was the reduction of WHC after pro-
tective ileostomy closure. WHC were defined as any condi-
tion of the wound that required postoperative intervention 
other than a change of dressing or removal of stiches.
Secondary endpoints were the incidence of SSI, postop-
erative length of hospital stay (LOS) and the duration of 
CWH. CWH was defined as complete closure of the wound 
without any secretion from the wound, as assessed at the 
outpatient clinic or reported by the patient. Incisional SSI 
diagnosis were made according to the criteria of the Center 
for Disease Control (CDC) and European Centre for Disease 
Prevention and Control (ECDC) for diagnosis of SSI [19, 
20].
Statistical analysis
Continuous data are presented as the medians and inter-
quartile ranges, unless otherwise indicated. Continuous 
variables were compared using the Mann–Whitney test and 
Student’s t-test. Categorical variables were compared using 
the chi-square test, including Yates’ correction or Fisher’s 
exact test when necessary. The level of significance was set 
at p < 0.05. Logistic regression models were used to detect 
possible risk factors for WHC and SSI incidence. In the case 
of LOS and CWH, simple linear regressions were used to 
determine potentially relevant factors, and then multiple 
regression models were created. Analyses were performed 
with Statistica 13.5.
Results
A total of 75 patients were randomized to the study. Four 
patients (5.3%) were lost to follow-up (two were lost as a 
result of reoperation, one was transferred to another ward, 
and one was excluded because of a technical problem with 
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NPWT device—difficulties with maintaining airtightness), 
and none of those patients developed WHC or SSI within 
30 days. Patient flow through the study is presented in Fig. 1.
Table 1 shows patients’ baseline characteristics before 
ileostomy closure. In the two study groups, 35 patients were 
treated with postoperative NPWT (24 males [68.6%]; mean 
age 61.6 ± 11.3 years), and 36 patients (20 males[55.6%]; 
mean age 62.4 ± 11.3 years) were treated with suturing of 
the wound and traditional dressings (control group). No sig-
nificant differences between the two groups were observed 
in patient characteristics or preoperative treatments. Surgi-
cal outcomes are shown in Table 2, and WHC are shown 
in Table 3. WHC were observed in 3 (8.6%) patients in 
the NPWT group and 11 (30.6%) in the control group 
(p = 0.020). SSI was observed in two (5.7%) patients with 
NPWT and in eight (22.2%) patients in the control group 
(p = 0.046). The median LOS was 3 (2–4) days in the NPWT 
group and did not significantly differ from that in the control 
group, 4 (2.5–5) days. The median duration of wound heal-
ing in patients with NPWT and in control groups was 7 (7–7) 
and 7 (7–15.5) days, respectively (p = 0.030).
To identify potential risk factors for WHC, univariate 
logistic regression models were constructed, as presented 
in Table 4. The univariate analyses revealed that only post-
operative NPWT significantly decreased the odds ratio for 
WHC incidence. In the case of risk factors for SSI, none 
of the factors analyzed in the univariate regression model 
were statistically significant. Simple linear regression 
models were built for the length of hospital stay and CWH 
time. In the LOS regression model, the adjusted R2 for 
multiple regression was 60.68% with a p value < 0.001. In 
this model, the factors identified as significantly prolonging 
LOS were: SSI by 4.58 days (2.62–6.54), other complica-
tions by 8.65 days (6.20–11.10), and BMI < 18.5 kg/m2 by 
7.36 days (1.22–13.50). Of all the factors analyzed in the 
simple regression models, only postoperative use of NPWT 
was significant. NPWT use was associated with shortening 
CWH by 3.00 ± 1.24 days in simple regression model with 
an adjusted R2 of 6.42% (p value < 0.001).
Discussion
To the best of our knowledge, this is the first study confirm-
ing the usefulness of postoperative NPWT in reducing the 
number of WHC associated with elective ileostomy closure 
in patients after surgery for colorectal cancer [14, 15]. Our 
study showed that the use of postoperative NPWT after 
ileostomy reversal procedures significantly reduces the risk 
of complications. This may have significant clinical impli-
cations, especially taking into considerations studies that 
suggest the benefits of early closure of the ileostomy, even 
before adjuvant chemotherapy [7]. However, concern over 
complications after ileostomy closure often postpones this 
procedure until the end of adjuvant chemotherapy. Postop-
erative NPWT may be an adequate solution of that clinical 
problem.
Although the risk of anastomotic leak after colorectal 
cancer surgery is reduced by diverting ileostomy, oppo-
nents argue it creates the need for another surgery with a 
Fig. 1  CONSORT flow dia-
gram. NPWT negative-pressure 
wound therapy
Assessed for eligibility (n=121) 
Excluded  (n=46) 
Not meeting inclusion criteria (n= 36) 
Declined to participate (n=0) 
Meet exclusion criteria (n=10) 
Analysed  (n=35) 
Lost to follow-up (1 Reoperation, 1 Transferred in 2 
post operation day to other word, 1 Technical 
problem with NPWT placement) (n=3)
Allocated to NPWT group (n=38) 
Received allocated intervention (n=38)
Lost to follow-up (1 Reoperation) (n=1) 
Allocated to intervention (n=37) 
Received allocated intervention (n=37)
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relatively high risk of complications [21]. Although those 
tend to be relatively mild and local complications, they may 
cause a delay in adjuvant chemotherapy, which diminishes 
the results obtained by oncological treatment. One method 
to minimize the risk of complications after the ileostomy 
closure is protective NPWT placement. There is a very large 
divergence in the reported incidences of infectious com-
plications after ileostomy reversal. Studies that deal with 
other issues related to surgery report a very low incidence 
of these complications [21]; however, research focusing on 
the impact of various surgical techniques on the incidence 
of SSI reports up to 40% risk of SSI in control groups. This 
relatively high incidence of SSI has led the American Col-
lege of Surgeons (ACS) to recommend closing wounds after 
ileostomy reversal using the purse-string technique [10]. Our 
study was designed between 2015 and 2016, prior to the 
2017 publication of the ACS recommendations to use the 
purse-string technique for closure of this type of wound [10]. 
Until then, simple suture technique was the standard, which 
is why in the control group simple suturing of the wound 
was applied. Because the proposed technique significantly 
extends healing time and often, especially in obese people, 
gives an unsatisfactory cosmetic effect [9, 11, 12], many sur-
geons still close their ileostomy wounds with conventional 
Table 1  Groups characteristics
NPWT negative pressure wound therapy
SD standard deviation
ASA American Society of Anaesthesiologists class
AJCC American Joint Committee on Cancer tumor stage
IQR inter−quartile range
TaTME transanal total mesorectum excision
Parameter Group 1 NPWT Group 2 control p value
Number of patients, n 35 36 n/a
Females, n (%) 11 (31.4%) 16 (44.4%) 0.259
Males, n (%) 24 (68.6%) 20 (55.6%)
Mean age, years ± SD 61.6 ± 11.3 62.4 ± 11.3 0.974
Body mass index, kg/m2 ± SD 26.2 ± 4.5 26.2 ± 4.3 0.794
ASA 1, n (%) 1 (2.9%) 1 (2.8%) 0.943
ASA 2, n (%) 22 (62.9%) 24 (66.7%)
ASA 3, n (%) 12 (34.2%) 11 (30.5%)
Any comorbidity, n (%) 25 (71.4%) 26 (72.2%) 0.942
Cardiovascular disease, n (%) 11(31.4%) 7 (19.4%) 0.252
Hypertension, n (%) 18(51.4%) 13 (36.1%) 0.199
Diabetes, n (%) 5 (14.3%) 5 (13.9%) 0.962
Pulmonary disease, n (%) 3 (8.6%) 4 (11.1%) 0.724
Renal disease, n (%) 2 (5.7%) 2 (5.6%) 0.977
Other comorbidity, n (%) 15 (42.8%) 14 (38.9%) 0.738
Smoking, n (%) 5 (14.3%) 6 (16.7%) 0.785
Immunosuppressive treatment, n (%) 3 (8.6%) 1 (2.8%) 0.297
Radiotherapy n (%) 27 (77.1%) 29 (80.6%) 0.729
Chemotherapy (pre- or postoperative), n (%) 27 (77.1%) 28 (77.8%) 0.950
AJCC Stage 0, n (%) 7 (20%) 11 (30.6%) 0.319
AJCC Stage I, n (%) 7 (20.0%) 9 (25.0%)
AJCC Stage II, n (%) 7 (20.0%) 7 (19.4%)
AJCC Stage III, n (%) 13 (37.1%) 6 (16.7%)
AJCC Stage IV, n (%) 1 (2.9%) 3 (8.3%)
Median time between operations, days (IQR) 148 (17–687) 139 (25–517) 0.296
Previous operation
 Hemicolectomy, n (%) 4 (11.4%) 4 (11.1%) 0.829
 Colectomy, n (%) 2 (5.7%) 2 (5.5%)
 Anterior resection of rectum n (%) 8 (22.9%) 13 (36.1%)
 Intersphincter resection n (%) 3 (8.6%) 4 (11.1%)
 TaTME, n (%) 18 (51.4%) 15 (41.7%)
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primary closure [21]. The use of postoperative NPWT pro-
vides the opportunity to combine the benefits of both tech-
niques. We suppose, based on our experience, that the heal-
ing time and final cosmetic effect do not differ from those of 
the primary closure technique. Additionally, NPWT offers 
a significant reduction in the occurrence of WMC and SSI 
compared with the effects of using the purse-string technique 
[11–13].
Several clinical trials have investigated the usefulness of 
postoperative NPWT in reducing postoperative infections, 
but the majority of them have been conducted in fields other 
than gastrointestinal surgery [15]. Only a few studies have 
been conducted in the field of general, oncological, or diges-
tive surgery [14], and only one article has described the use 
of NPWT as a postoperative dressing in patients after divert-
ing ileostomy closure [22]. The results of this study differ 
from our observations. In the cited study, the wound after 
ileostomy was closed using the purse-string suture tech-
nique; for this reason, even in the group without complica-
tions, the wound healing time was longer than 30 days [22]. 
In our study, even in the group of patients with an infec-
tious complication, CWH was shorter than 30 days. In our 
research, the NPWT application was limited to 72 h after the 
surgery and was used only to evacuate the exudate or hema-
toma from the wound. The dressing was placed in sterile 
conditions of the operating room over the cleaned wound 
while the antibiotic prophylaxis used for the operation was 
still in effect. In the cited study, a NPWT was installed 24 h 
after surgery and maintained for more than 2 weeks, which 
in our opinion may increase the potential for colonization 
of the wound and possible development of infectious com-
plications. In the previously cited meta-analysis of all other 
clinical trials of NPWT in the postoperative period, its use 
was shorter, ranging from 3 to 7 days, and the dressing was 
placed over the wound immediately after the surgery [15]. 
Another difference between our study that of Uchino et al. 
concerns the intervention population. Our research included 
patients who underwent surgery for colorectal cancer, 
mainly rectal cancer, which particularly exposes them to 
the risk of infectious complications. The majority of them 
Table 2  Peri- and postoperative 
outcomes in analysed groups
Significant p-values were marked with bolded font
NPWT negative pressure wound therapy
SD standard deviation
IQR inter−quartile range
Parameter Group 1 NPWT Group 2 control p value
Number of patients, n 35 36 n/a
Median operative time, minutes (IQR) 57 (50–73) 55 (52–70) 0.856
Mean perioperative blood loss, ml ± SD 16 ± 9 18 ± 10 0.654
Patients without any complications, n (%) 30 (85.7%) 23 (63.9%) 0.035
Patients with complications, n (%) 5 (14.3%) 13 (36.1%)
Clavien-Dindo grade 1, n (%) 4 (11.4%) 6 (16.7%) n/a
Clavien-Dindo grade 2, n (%) 1 (2.9%) 5 (13.9%)
Clavien-Dindo grade 3, n (%) – 2 (5.6%)
Clavien-Dindo grade 4, n (%) – –
Clavien-Dindo grade 5, n (%) – –
Median length of postoperative hospital stay, days (IQR) 3 (2–4) 4 (2.5–5) 0.072
Median duration of complete wound healing time days (IQR) 7 (7–7) 7 (7–15.5) 0.030
Table 3  Postoperative wound 
management complications 
(WMC)
Significant p-values were marked with bolded font
Complication Group 1 NPWT Group 2 Control p value
Number of WMC, n (%) 3 (8.57%) 11(30.6%) 0.020
Surgical site infections (SSI), n (%) 2 (5.71%) 8 (22.2%) 0.046
Superficial SSI, n (%) 2 (5.71%) 4 (11.1%) n/a
Deep SSI, n (%) 0 3 (38.8%) n/a
Organ SSI 1, n (%) 0 1 (2.8%) n/a
Hematoma, n (%) 0 3 (8.3%) n/a
Seroma, n (%) 1 (2.9%) 1(2.8%) 0.984
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were elderly with numerous comorbidities and higher BMI. 
Additionally, most of them underwent radio- and chemo-
therapy shortly before the surgery. In the Uchino study, the 
population consisted of patients who had surgery as a result 
of ulcerative colitis, resulting in a significantly lower number 
of infectious complications in the control group than in our 
study. Given these differences, we believe that these two 
studies are not directly comparable, as they concern differ-
ent issues. To increase the chance of achieving statistical 
significance while limiting the necessary study population, 
the cumulative index of WHC, not the occurrence of SSI, 
was established as the primary outcome. With the incidence 
of SSI in our group of patients and expected reduction of 
SSI cases by approximately 50%, the minimal sample size 
would have required recruitment of 80 patients in each arm. 
However, the observed effect of intervention exceeded our 
expectations. A statistically significant effect of the use of 
NPWT on reducing the incidence of SSI was confirmed.
Our study showed that the use of postoperative NPWT 
dressing is safe. In the NPWT group, there was no increase 
in the percentage of postoperative complications, as well 
as no case of a complication that could be linked directly 
to NPWT use (postoperative bleeding or entero-cutaneous 
fistula formation). In the group of patients with NPWT, 
both the time of hospitalization and the time of healing of 
the surgical wound were shortened.
Limitations
Because of the actual incidence of WHC in this study dif-
fering from the values assumed during the sample size 
calculation, the post hoc analysis revealed that the study of 
the primary outcome, despite obtaining statistically signif-
icant differences, achieved 65% power and not the assumed 
80%. The obtained results are therefore underpowered.
Also, our study used only one type of NPWT device. 
Comparison of the effectiveness and safety of other types 
of NPWT equipment in this application will require fur-
ther research.
We did not specifically analyze the time period between 
chemotherapy and operation, but we observed no differ-
ence in the incidence of postoperative chemotherapy 
between groups, and the time from colorectal resection 
and ileostomy closure until chemotherapy did not differ 
between groups.
We did not perform an analysis of the cosmetic effect of 
our treatment. Further research in this area is required.
Lastly, this study was a single-center study, which, on one 
hand, is a strength in the consistent treatment of all patients, 
but on the other hand, it will require confirmation in multi-
center studies on larger groups of patients.
Table 4  Univariate logistic 
regression analyses of WMC 
incidence
Significant p-value was marked with bolded font
WMC wound management complication
NPWT negative pressure wound therapy
BMI body mass index
TaTME transanal total mesorectum excision
AJCC American Joint Committee on Cancer tumor stage
Parameter OR (95% CI) p value
Postoperative NPWT (yes vs. no) 0.19 (0.04–0.97) 0.041
Sex (female vs. male) 0.74 (0.15–3.72) 0.704
Age (≥ 75 vs. < 75 years) 1.72 (0.16–18.91) 0.650
BMI (≥ 30 vs. < 30 kg/m2) 2.07 (0.33–13.18) 0.429
Smoking (yes vs. no) 0.34 (0.03–4.68) 0.719
Radiotherapy (yes vs. no) 1.02 (0.04–27.13) 0.992
Chemotherapy (yes vs. no) 0.92 (0.04–23.07) 0.926
Paraostomal hernioplasty (yes vs. no) 0.44 (0.03–5.98) 0.532
Time between previous operation (≥ 365 vs < 365 days) 3.08 (0.23–40.65) 0.381
Cardiovascular disease (yes vs. no) 0.67 (0.10–4.69) 0.685
Diabetes (yes vs. no) 1.44 (0.19–11.13) 0.719
Pulmonary disease (yes vs. no) 0.79 (0.06–10.61) 0.858
Renal disease (yes vs. no) 3.39 (0.13–90.93) 0.457
TaTME (yes vs. no) 1.25 (0.25–6.34) 0.780
AJCC IV (yes vs. no) 2.19 (0.09–51.96) 0.619
Complications not related to wound management 0.83 (0.25–2.77) 0.762
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Conclusions
Prophylactic postoperative NPWT after diverting ileostomy 
closure in colorectal cancer patients reduces the incidence of 
WHC, SSI, and complete wound healing time.
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